Shape and Size Controlled Pt Nanocrystals as Novel Model Catalysts

Designing Sites in Heterogeneous Catalysis: Are We Reaching Selectivities Competitive With Those of Homogeneous Catalysts?

A critical review of different prominent nanotechnologies adapted to catalysis is provided, with focus on how they contribute to the improvement of selectivity in heterogeneous catalysis. Ways to modify catalytic sites range from the use of the reversible or irreversible adsorption of molecular modifiers to the immobilization or tethering of homogeneous catalysts and the development of well-defined catalytic sites on solid surfaces. The latter covers methods for the dispersion of single-atom sites within solid supports as well as the use of complex nanostructures, and it includes the post-modification of materials via processes such as silylation and atomic layer deposition. All these methodologies exhibit both advantages and limitations, but all offer new avenues for the design of catalysts for specific applications. Because of the high cost of most nanotechnologies and the fact that the resulting materials may exhibit limited thermal or chemical stability, they may be best aimed at improving the selective synthesis of high value-added chemicals, to be incorporated in organic synthesis schemes, but other applications are being explored as well to address problems in energy production, for instance, and to design greener chemical processes. The details of each of these approaches are discussed, and representative examples are provided. We conclude with some general remarks on the future of this field.

Facile Synthesis of Platinum Right Bipyramids by Separating and Controlling the Nucleation Step in a Continuous Flow System

Colloidal synthesis of metal nanocrystals with controlled shapes and internal structures calls for a tight control over both the nucleation and growth processes. Here we report a method for the facile synthesis of Pt right bipyramids (RBPs) by separating nucleation from growth and controlling the nucleation step in a continuous flow reactor. Specifically, homogeneous nucleation was thermally triggered by introducing the reaction solution into a tubular flow reactor held at an elevated temperature to generate singly-twinned seeds. At a lower temperature, the singly-twinned seeds were protected from oxidative etching to allow their slow growth and evolution into RBPs while additional nucleation of undesired seeds could be largely suppressed to ensure RBPs as the main product. Further investigation indicated that the internal structure and growth pattern of the seeds were determined by the temperatures used for the nucleation and growth steps, respectively. The Br^- ions involved in the synthesis also played a critical role in the generation of RBPs by serving as a capping agent for the Pt{100} facets while regulating the reduction kinetics through coordination with the Pt(IV) ions.

A Comprehensive Review on the Synthesis, Characterization, and Biomedical Application of Platinum Nanoparticles

Platinum nanoparticles (PtNPs) are noteworthy scientific tools that are being explored in various biotechnological, nanomedicinal, and pharmacological fields. They are unique because of their large surface area and their numerous catalytic applications such as their use in automotive catalytic converters and as petrochemical cracking catalysts. PtNPs have been widely utilized not only in the industry, but also in medicine and diagnostics. PtNPs are extensively studied because of their antimicrobial, antioxidant, and anticancer properties. So far, only one review has been dedicated to the application of PtNPs to nanomedicine. However, no studies describe the synthesis, characterization, and biomedical application of PtNPs. Therefore, the aim of this review is to provide a comprehensive assessment of the current knowledge regarding the synthesis, including physical, chemical, and biological and toxicological effects of PtNPs on human health, in terms of both in vivo and in vitro experimental analysis. Special attention has been focused on the biological synthesis of PtNPs using various templates as reducing and stabilizing agents. Finally, we discuss the biomedical and other applications of PtNPs.

Sensitive measurement of tumor markers somatostatin receptors using an octreotide-directed Pt nano-flakes driven electrochemical sensor

Tumor markers play an important role in the early diagnosis and therapeutic effect monitoring of tumors. An electrochemical biosensor was developed based on multi-branched gold nanoshells (BGSs) and octreotide (OCT) functionalized Pt nano-flakes (PtNFs) modified electrodes, which was used for detection of tumor-specific markers to evaluate tumor cells. Sandwich-type nano-hybrid materials were prepared by layer-by-layer modification. First, reduced graphene oxide (RGO) and BGSs were modified as electronic materials onto glassy carbon electrodes (GCE). This modified electrode has strong electron transfer capability and large electrode surface area. The OCT was then anchored to the surface of BGSs to sensitively detect Somatostatin receptors (SSTRs) on the surface of HeLa cells. In addition, PtNFs were synthesized using a dual-template method, and OCT template on the surface of PtNFs, as an adsorption bioprobe, was used to reduce the H₂O₂ and amplify the electrochemical signal of biosensor. The proposed biosensor can be applied to the quantitative broad linear range of HeLa cells covering from 10 to 1 × 10⁶ cells mL^-1 (R² = 0.9998) and the limit of detection (LOD) was 2 cells mL^-1. The experimental results also show that the sensor has good stability, biocompatibility and high selectivity, which has great potential for clinical application.

Platinum nanoparticles in nanobiomedicine

Oxidative stress-dependent inflammatory diseases represent a major concern for the population's health worldwide. Biocompatible nanomaterials with enzymatic properties could play a crucial role in the treatment of such pathologies. In this respect, platinum nanoparticles (PtNPs) are promising candidates, showing remarkable catalytic activity, able to reduce the intracellular reactive oxygen species (ROS) levels and impair the downstream pathways leading to inflammation. This review reports a critical overview of the growing evidence revealing the anti-inflammatory ability of PtNPs and their potential applications in nanomedicine. It provides a detailed description of the wide variety of synthetic methods recently developed, with particular attention to the aspects influencing biocompatibility. Special attention has been paid to the studies describing the toxicological profile of PtNPs with an attempt to draw critical conclusions. The emerging picture suggests that the material per se is not causing cytotoxicity, while other physicochemical features related to the synthesis and surface functionalization may play a crucial role in determining the observed impairment of cellular functions. The enzymatic activity of PtNPs is also summarized, analyzing their action against ROS produced by pathological conditions within the cells. In particular, we extensively discuss the potential of these properties in nanomedicine to down-regulate inflammatory pathways or to be employed as diagnostic tools with colorimetric readout. A brief overview of other biomedical applications of nanoplatinum is also presented.

Controlling the size of Pt nanoparticles with a cationic surfactant, CnTABr

We report how the size of Pt nanoparticles varies by using a wide range of chain lengths and concentrations of C_nTABr, a cationic surfactant, in aqueous-based colloidal synthesis and confirm that the chemical affinity between the organic complex formed in the solution and the aggregate of the surfactant is an important factor for Pt particle growth.

Pt and Pt–Rh supercrystals self-assembled in N,N-dimethylformamide

N,N-Dimethylformamide (DMF) serves as the facet-specific agent for the formation of a cubic shape and the structure-directing agent for the self-assembly of Pt and Pt–Rh building blocks of the supercrystals.

Polyelectrolyte assisted synthesis and enhanced oxygen reduction activity of Pt nanocrystals with controllable shape and size

The shape control of platinum nanocrystals is significant to the enhancement of their catalytic performance in terms of activity and selectivity. However, it still remains a major challenge to prepare Pt nanocrystals with tunable shape and clean surface in an eco-friendly way. This article develops a facile and green strategy to prepare well tuned platinum nanocrystals employing poly(diallyldimethylammonium chloride) (PDDA) as the capping agent, reductant, and stabilizer simultaneously in a facile hydrothermal process. It is identified that the variation of PDDA concentration is crucial to control the growth of crystalline facets, leading to the formation of cubic, truncated cubic, and octahedral Pt nanocrystals with sizes tunable from ca. 17 nm to ca. 50 nm. The resultant Pt nanocrystals exhibit excellent electrocatalytic activity and stability toward the oxygen reduction reaction (ORR) in acidic media compared with those of commercial Pt black and the state-of-the-art Pt/C catalyst. It is proposed that the preferential Pt surface and the decoration of PDDA, which modulates the electronic structures and electrooxidation of Pt nanocrystals, synergistically contribute to the enhanced catalytic performance.

Shape-controlled nanostructures in heterogeneous catalysis

Nanotechnologies have provided new methods for the preparation of nanomaterials with well-defined sizes and shapes, and many of those procedures have been recently implemented for applications in heterogeneous catalysis. The control of nanoparticle shape in particular offers the promise of a better definition of catalytic activity and selectivity through the optimization of the structure of the catalytic active site. This extension of new nanoparticle synthetic procedures to catalysis is in its early stages, but has shown some promising leads already. Here, we survey the major issues associated with this nanotechnology-catalysis synergy. First, we discuss new possibilities associated with distinguishing between the effects originating from nanoparticle size versus those originating from nanoparticle shape. Next, we survey the information available to date on the use of well-shaped metal and non-metal nanoparticles as active phases to control the surface atom ensembles that define the catalytic site in different catalytic applications. We follow with a brief review of the use of well-defined porous materials for the control of the shape of the space around that catalytic site. A specific example is provided to illustrate how new selective catalysts based on shape-defined nanoparticles can be designed from first principles by using fundamental mechanistic information on the reaction of interest obtained from surface-science experiments and quantum-mechanics calculations. Finally, we conclude with some thoughts on the state of the field in terms of the advances already made, the future potentials, and the possible limitations to be overcome.